The most preventable ED returns cluster in the first 0–72 hours after discharge, when clinical risk is still high and operational risk is even higher: medications are missing, follow-up is not scheduled, referrals leak, and patients do not yet know what “worsening” looks like. Strong Avoidable Utilization Governance treats this period as a controlled system, not a hopeful handoff. It works best when aligned with Primary Care & Care Coordination, because the core task is coordination reliability: who owns the next step, by when, and what happens when the plan fails.
Why 0–72 Hours After Discharge Is a Governance Problem
Discharge instructions often assume ideal conditions: the patient fills prescriptions, understands warning signs, attends follow-up, and receives home services on time. Real systems are messier. Authorizations lag, pharmacies are out of stock, home health cannot start, transportation fails, and families realize they cannot manage. Each failure produces the same end result: rising risk with no rapid alternative, and the ED becomes the default escalation path.
Governance needs to harden the discharge “plan” into operational controls: time-bound tasks, acceptance confirmation, escalation authority, and assurance checks that prove follow-up actually happened. The aim is not to eliminate all ED use—it is to make avoidable returns measurably rarer by removing predictable gaps.
Operational Example 1: 0–24 Hour Contact Standard With a Structured Verification Script
What happens in day-to-day delivery: The organization sets a 0–24 hour standard for post-discharge contact for defined cohorts (e.g., recent hospitalization, high-risk meds, new oxygen, CHF/COPD exacerbation, complex wounds, frailty/falls history). A care coordinator or transition nurse calls (or visits where feasible) using a structured script that verifies: the patient is home and safe, prescriptions were obtained, the dosing plan is understood, symptoms are stable, durable medical equipment is present, and follow-up appointments are known with date/time. The script includes “red flag” symptom prompts and a clear escalation pathway. Findings are documented in a way that creates an audit trail: what was verified, what was missing, and what actions were initiated.
Why the practice exists (failure mode it addresses): This exists to prevent the failure mode where teams assume discharge instructions were understood and medications were obtained. The earliest failures—missing meds, confusion, inability to self-manage—often occur within hours, not days, and they become ED triggers if not identified quickly.
What goes wrong if it is absent: Without a 0–24 hour verification standard, gaps remain invisible until they present as urgent deterioration, uncontrolled symptoms, or caregiver panic. Patients may take medications incorrectly, miss critical follow-up, or fail to escalate early because they do not know what warrants action. ED use appears “unavoidable,” but it is often the result of undetected operational failure.
What observable outcome it produces: This control produces measurable reliability: higher rates of medication possession within 24 hours, fewer urgent “I don’t know what to do” calls, and reduced ED visits driven by confusion or access barriers. Evidence includes completion rates for post-discharge contacts, documented gap resolution, and reduced returns within the first 72 hours for the targeted cohort.
Operational Example 2: Medication Access and Reconciliation “Hard Stop” Within 24–48 Hours
What happens in day-to-day delivery: The organization implements a medication access and reconciliation hard stop for discharges involving high-risk medication changes (new anticoagulant, insulin changes, opioids, antipsychotics, diuretics, multiple new meds, or discontinuations). A designated medication lead (pharmacist partner, nurse, or trained medication coordinator) confirms what was prescribed, what was dispensed, and what the patient is actually taking. The workflow includes barrier resolution: prior authorization escalation, emergency supply coordination where permitted, pharmacy delivery arrangements, blister packaging or med box set-up, and clear written dosing instructions. If reconciliation cannot be completed, the issue is escalated the same day to a clinical reviewer with authority to coordinate the prescriber’s response.
Why the practice exists (failure mode it addresses): This exists to address a common failure mode: “paper reconciliation” without real-world possession and adherence. Medication-related ED visits often stem from missed fills, duplicate therapy, unrecognized interactions, or patients resuming old meds because new ones were unavailable or confusing.
What goes wrong if it is absent: Without an access-and-reconciliation hard stop, patients leave the hospital with a theoretical plan and a practical gap. They may take conflicting regimens, skip critical meds, or overuse symptom-relief medications. The first sign may be hypoglycemia, bleeding risk, fluid overload, severe pain rebound, or delirium—conditions that rapidly lead to ED care.
What observable outcome it produces: The observable outcomes include fewer medication-related ED visits, improved documented reconciliation accuracy, and faster resolution of authorization barriers. Audit evidence includes confirmed possession, resolved discrepancies, and documented prescriber engagement when regimen adjustments are needed.
Operational Example 3: Closed-Loop Follow-Up Scheduling and “No-Start” Escalation for Services
What happens in day-to-day delivery: Follow-up is managed as a closed loop with time standards: primary care follow-up confirmed within 7 days (or sooner for higher risk), specialty follow-up confirmed where relevant, and home services start-of-care confirmed (or “no-start” escalated) within defined windows. A referral owner maintains a post-discharge register that tracks: referral sent, acceptance confirmed, scheduled date/time, service delivered, and outcome returned. If a home service cannot start, escalation authority triggers alternatives (re-routing to another provider, interim telehealth monitoring, urgent clinic appointment, or increased care management contact frequency) and documents the gap plan.
Why the practice exists (failure mode it addresses): This exists to prevent referral leakage and delayed follow-up, which is one of the most consistent drivers of early ED returns. “We referred” is not a control. Acceptance and scheduling are the control points that determine whether the plan exists in reality.
What goes wrong if it is absent: Without closed-loop scheduling and no-start escalation, patients assume services are arranged and reduce their own vigilance. When services fail to start, symptoms worsen and caregivers escalate to the ED. The system then experiences blame-shifting between discharge teams and community providers, with no auditable record of where the process failed.
What observable outcome it produces: Closed-loop follow-up produces measurable improvements: higher confirmed appointment rates, fewer no-start events, fewer urgent gaps in home support, and reduced early ED returns. Governance can evidence acceptance timeliness, escalation actions taken, and improved follow-up completion in high-risk cohorts.
Oversight Expectations: What System Partners Expect to See
Expectation 1: Funders and system partners increasingly expect proof that post-discharge follow-up is achieved, not just planned. This typically means documented outreach, verified medication access, and confirmed follow-up scheduling—supported by auditable registers and completion reporting.
Expectation 2: Reviews after early adverse events often focus on whether the organization had time-bound controls and escalation authority when the plan failed. Governance should be able to show what was verified, what was missing, who owned the gap, and what interim supports were implemented.
Governance and Assurance: Making the First 72 Hours Measurably Safer
Leaders should track leading indicators (contact completion within 24 hours, medication possession and reconciliation completion, acceptance lag for services, no-start rates) alongside lagging indicators (0–72 hour ED returns, 7/30-day revisits). Assurance sampling should test whether “closed” tasks are truly closed: medications in hand, visits completed, and outcomes documented.
When the first 72 hours are governed, the system is no longer surprised by predictable gaps. It becomes capable of preventing avoidable returns by design—and proving that prevention happened.